Delivery Order SPE2DR25D1053-SPE2DR26FV545
Award Date 1/14/26
Potential Completion Date 2/5/26
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $39,918.40 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 280 mg tablets (28-count packages), with an ultimate completion date of December 12, 2025. This non-set-aside contract represents a competitive award for pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Department of Defense's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for IMBRUVICA 420 mg tablets (28-count units) with a ceiling value of $15,967.36 under a firm fixed-price contract type. The award was made on December 2, 2025, with an ultimate completion date of December 23, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. IMBRUVICA (ibrutinib) is a prescription medication used to treat...
- The Defense Logistics Agency awarded a $15,967.36 delivery order to AmerisourceBergen Drug Corp for 28 Imbruvica 70 mg capsules on November 17, 2025, with completion targeted for December 9, 2025. This firm fixed-price delivery order utilizes no set-aside designation and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,233.74 on September 22, 2025, for the supply of Imbruvica 140 mg capsules (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Imbruvica is a prescription medication used primarily in the treatment of certain blood cancers and immune...
- On January 9, 2026, the Defense Logistics Agency awarded a $20,915.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 280 milligram Imbruvica tablets (28-count packaging), with delivery expected by February 2, 2026. The award was made on a non-set-aside, competitive basis and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a major pharmaceutical distributor providing critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 140 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $8,116.87. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 17, 2025. The vendor will perform the contract from its corporate headquarters in Conshohocken, Pennsylvania. IMBRUVICA is a specialized pharmaceutical product used in the...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,845.72 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 140 mg Imbruvica capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,233.74 for IMBRUVICA 140 mg capsules (90-count units) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on July 28, 2025, with an ultimate completion date of August 18, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $11,405.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (120-count units) on November 28, 2025. This is a firm fixed price, non-set-aside contract with a completion date of December 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) with a ceiling value of $31,934.72. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on December 16, 2025, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...